semaglutide development history Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare GLP-1-based therapies for diabetes, obesity

This precision eliminates the trial-and-error approach and the temptation to combine medications in search of faster results

Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight

Beyond technique alone, individual variations in how patients respond to GLP-1 therapyincluding tolerance, efficacy, and side effect profilesmay be influenced by genetic predispositions in key peptide pathways

Walker, S

When our skin has less melanin, it starts to get fair

Properdistatin, a new peptide generated from the plasma protein properdin, inhibited angiogenesis in A-07 human melanoma xenografts, according to Wu et al